Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells

Advanced Drug Delivery Reviews

Volumn 41, Issue 2, 2000, Pages 171-188

  Rao, Mangala ^a   Alving, Carl R ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Liposomal antigens; Liposomal lipids; Liposomal proteins; Vaccines

Indexed keywords

ANTIBODIES; ANTIGENS; CELLS; ENCAPSULATION; ENZYMES; IMMUNOLOGY; LIPIDS; PROTEINS; VACCINES;

ANTIGEN PRESENTING CELLS; CYTOPLASM; GOLGI; LIPOSOMAL PROTEINS; PHAGOCYTES;

CONTROLLED DRUG DELIVERY;

DRUG CARRIER; LIPID A; LIPOSOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VACCINE;

ANTIGEN PRESENTING CELL; CELLULAR IMMUNITY; CYTOPLASM; CYTOTOXIC T LYMPHOCYTE; DRUG DELIVERY SYSTEM; GOLGI COMPLEX; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; T LYMPHOCYTE; VACCINATION;

EID: 0343938832     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(99)00064-2     Document Type: Article

References (87)

1. Gregoriadis G. Immunological adjuvants: a role for liposomes. Immunol. Today. 11:1990;89-97.
2. Alving C.R. Liposomes as carriers of antigens and adjuvants. J. Immunol. Methods. 140:1991;1-13.
3. Alving C.R., Koulchin V., Glenn G.M., Rao M. Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides. Immunol. Rev. 145:1995;5-31.
4. Fries L.F., Gordon D.M., Richards R.L., Egan J.E., Hollingdale M.R., Gross M., Silverman C., Alving C.R. Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy. Proc. Natl. Acad. Sci. USA. 89:1992;358-362.
5. Wassef N.M., Alving C.R., Richards R.L. Liposomes as carriers for vaccines. Immunomethods. 4:1994;217-222.
6. Allison A.G., Gregoriadis G. Liposomes as immunological adjuvants. Nature. 252:1974;252.
7. Uemura K., Nicolotti R.A., Six H.R., Kinsky S.C. Antibody formation in response to liposomal model membranes sensitized with N-substituted phosphatidylethanolamine derivatives. Biochemistry. 13:1974;1572-1578.
8. Braciale T.J., Morrison L.A., Sweetser M.T., Sambrook J., Gething M.J., Braciale V.L. Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes. Immunol. Rev. 98:1987;95-114.
9. Germain R.N., Margoulies D.H. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:1993;403-450.
10. Townsend A., Bodmer H. Antigen recognition by class I-restricted T lymphocytes. Annu. Rev. Immunol. 7:1989;601-624.
11. Moore M.W., Carbone F.R., Bevan M.J. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell. 54:1988;777-785.
12. Deres K., Schild H., Wiesmufler K.H., Jung G., Rammensee H.G. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature. 342:1989;561-564.
13. Schild H., Norda M., Deres K., Falk K., Rotzschke O., Wiesmuller K.H., Jung G., Rammensee H.G. Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide. J. Exp. Med. 174:1991;1665-1668.
14. Martinon F., Gras-Masse H., Boutillon C., Chirat F., Deprez B., Guillet J.-G., Gomard E., Tartar A., Levy J.P. Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein. J. Immunol. 149:1992;3416-3422.
15. Harding C.V., Song R. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J. Immunol. 153:1994;4925-4933.
16. Kovacsovics-Bankowski M., Rock K.L. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science. 267:1995;243-246.
17. Men Y., Tamber H., Audran R., Gsnder B., Corradin G. Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres. Vaccine. 15:1997;1405-1412.
18. Lopes L.M., Chain B.M. Liposome-mediated delivery stimulates a class I restricted cytotoxic T cell response to soluble antigen. Eur. J. Immunol. 22:1992;287-290.
19. Reddy R., Zhou F., Nair S., Huang L., Rouse B.T. In vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes. J. Immunol. 148:1992;1585-1589.
20. White K., Krzych U., Gordon T.D., Porter M.R., Richards R.L., Alving C.R., Deal C.D., Hollingdale M., Silverman C., Sylvester D.R., Ballou W.R., Gross M. Induction of cytolytic and antibody responses using Plasmodium falciparum repeatless circumsporozoite protein encapsulated in liposomes. Vaccine. 11:1993;1341-1346.
21. Alving C.R., Wassef N.M. Cytotoxic T lymphocytes induced by liposomal antigens: mechanisms of immunological presentation. AIDS Res. Hum. Retrovir. 10:1994;S91-S94.
22. White W.I., Cassatt D.R., Madsen J., Burke S.J., Woods R.M., Wassef N.M., Alving C.R., Koenig S. Antibody and cytotoxic T-lymphocyte responses to a single liposome-associated peptide antigen. Vaccine. 13:1995;1111-1122.
23. Su D., Van Rooijen N. The role of macrophages in the immunoadjuvant action of liposomes: effects of elimination of splenic macrophages on the immune response against intravenously injected liposome-associated albumin antigen. Immunology. 66:1989;466-470.
24. Verma J.N., Rao M., Amselem S., Krzych U., Alving C.R., Green S.J., Wassef N.M. Adjuvant effects of liposomes containing lipid A: enhancement of liposomal antigen presentation and recruitment of macrophages. Infect. Immun. 60:1992;2438-2444.
25. Rao M., Wassef N.M., Alving C.R., Krzych U. Intracellular processing of liposome encapsulated antigens by macrophages depends upon the antigen. Infect. Immun. 63:1995;2396-2402.
26. Rao M., Rothwell S.W., Wassef N.M., Pagano R.E., Alving C.R. Visualization of peptides derived from liposome-encapsulated proteins in the trans-Golgi area of macrophages. Immun. Lett. 59:1997;99-105.
27. Rao M., Rothwell S.W., Wassef N.M., Koolwal A.B., Alving C.R. Trafficking of liposomal antigen to the trans-Golgi of murine macrophages requires both liposomal lipid and liposomal protein. Exp. Cell Res. 246:1999;203-211.
28. Rock K.L., Rothstein L., Gamble S., Fleischacker C. Characterization of antigen-presenting cells that present exogenous antigens in association with class I molecules. J. Immunol. 150:1993;438-446.
29. Grant E.P., Rock K.L. MHC class I-restricted presentation of exogenous antigen by thymic antigen presenting cells in vitro and in vivo. J. Immunol. 148:1992;13-18.
30. Segal A.W., Willis E.J., Richmond J.E., Slavin G., Black C.D.V., Gregoriadis G. Morphological observations on the cellular and subcellular destination of intravenously administered liposomes. Br. J. Exp. Pathol. 55:1974;320-327.
31. Woodle M.C., Lasic D.D. Sterically stabilized liposomes. Biochim. Biophys. Acta. 1113:1992;171-199.
32. Rao M., Alving C.R. Class I presentation of liposomal antigens. Lasic D.D., Papahadjopoulos D. Medical Applications of Liposomes. 1998;15-24 Elsevier, New York.
33. Verma J.N., Wassef N.M., Wirtz R.A., Atkinson C.T., Aikawa M., Loomis L.D., Alving C.R. Phagocytosis of liposomes by macrophages: intracellular fate of liposomal malaria antigen. Biochim. Biophys. Acta. 1066:1991;229-238.
34. Alving C.R., Richards R.L. Immunological aspects of liposomes. Ostro M.J. Liposomes. 1983;209-287 Marcel Dekker, New York.
35. Beatty J.D., Beatty B.G., Paraskevas F., Froese E. Liposomes as immune adjuvants: T cell dependence. Surgery. 96:1984;345-351.
36. Shek P.N., Lukovich S. The role of macrophages in promoting the antibody response mediated by liposome-associated protein antigens. Immunol. Lett. 5:1982;305-309.
37. Norrie D.H., Pietrowski R.A., Stephen J. Screening the efficiency of intracytoplasmic delivery of materials to HeLa cells by liposomes. Anal. Biochem. 127:1982;276-281.
38. Rock K.L. A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today. 17:1996;131-137.
39. Nair S., Buiting A.M., Rouse R.J., Van Rooijen N., Huang L., Rouse B.T. Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses. Int. Immunol. 7:1995;679-688.
40. Nair S., Zhou F., Reddy R., Huang L., Rouse B.T. Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro. J. Exp. Med. 175:1992;609-612.
41. Hale A.H. H-2 antigens incorporated into phospholipid vesicles elicit specific allogeneic cytotoxic T lymphocytes. Cell. Immunol. 55:1980;328-341.
42. Hale A.H., McGee M.P. A study of the inability of subcellular fractions to elicit primary anti-H-2 cytotoxic T lymphocytes. Cell. Immunol. 58:1981;277-285.
43. Raphael L., Tom B.H. In vitro induction of primary and secondary xenoimmune responses by liposomes containing human colon tumor cell antigens. Cell. Immunol. 71:1982;224-240.
44. Raphael L., Tom B.H. Liposome facilitated xenogeneic approach for studying human colon cancer immunity: carrier and adjuvant effect of liposomes. Clin. Exp. Immunol. 55:1984;1-13.
45. Harding C.V., Collins D.S., Kanagawa O., Unanue E.R. Liposome-encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation. J. Immunol. 147:1991;2860-2863.
46. Reddy R., Zhou F., Huang L., Carbone F., Bevan M., Rouse B.T. pH sensitive liposomes provide an efficient means of sensitizing target cells to class I restricted CTL recognition of a soluble protein. J. Immunol. Methods. 141:1991;157-163.
47. Zhou F., Rouse B.T., Huang L. An improved method of loading pH-sensitive liposomes with soluble proteins for class I restricted antigen presentation. J. Immunol. Methods. 145:1991;143-152.
48. Nerome K., Yoshioka Y., Ishida M., Okuma K., Oka T., Kataoka T., Inoue A., Oya A. Development of a new type of influenza subunit vaccine made by muramyldipeptide liposome: enhancement of humoral and cellular immune responses. Vaccine. 8:1990;503-509.
49. Collins D.S., Findlay K., Harding C.V. Processing of exogenous liposome-encapsulated antigens in vivo generates class I MHC-restricted T cell responses. J. Immunol. 148:1992;3336-3341.
50. Defoort J.P., Nardelli B., Huang W., Tam J.P. A rational design of synthetic peptide vaccine with a built-in adjuvant. Int. J. Pept. Prot. Res. 40:1992;214-221.
51. Walker C., Selby M., Erickson A., Cataldo D., Valensi J., Van Nest G. Cationic lipids direct a viral glycoprotein into the class I major histocompatibility complex antigen presentation pathway. Proc. Natl. Acad. Sci. USA. 89:1992;7915-7918.
52. Chen W., Carbone F.R., McCluskey J. Electroporation and commercial liposomes efficiently deliver soluble protein into the MHC class I presentation pathway. J. Immunol. Methods. 160:1993;49-57.
53. Richards R.L., Rao M., Wassef N.M., Glenn G.M., Rothwell S.W., Alving C.R. Liposomes containing lipid A serve as an adjuvant for induction of cytotoxic T lymphocytes against RTS,S malaria antigen. Infect. Immun. 66:1998;2859-2865.
54. Rao M., Matyas G., Grieder F., Anderson K., Jahrling P., Alving C.R. Cytotoxic T lymphocytes to Ebola Zaire virus are induced in mice by immunization with liposomes containing lipid A. Vaccine. 17:1999;2991-2998.
55. + cytotoxic T lymphocytes. J. Exp. Med. 176:1992;1739-1744.
56. Yasutomi Y., Koenig S., Woods R., Madsen J., Wassef N.M., Alving C.R., Klein H.J., Boots L.J., Kessler J.A., Emini E.A., Conley A.J., Letvin N.L. A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous, cell-free simian immunodeficiency virus challenge. J. Virol. 69:1995;2279-2284.
57. Vogel F.R Powell M.F. Section on Walter Reed liposomes in a compendium of vaccine adjuvants. Powell M.F., Newman M.J. Vaccine Design: The Subunit and Adjuvant Approach. 1995;226-227 Plenum Press, New York.
58. Connor J., Huang L. Efficient cytoplasmic delivery of a fluorescent dye by pH-sensitive immunoliposomes. J. Cell Biol. 101:1985;582-589.
59. Duzgunes N., Straubiger R.M., Baldwin P.A., Friend D.S., Papahadjopoulos D. Proton induced fusion of oleic acid-phosphatidylethanolamine liposomes. Biochemistry. 24:1985;3091-3098.
60. Ellens H., Bentz J., Szoka F.C. pH-induced destabilization of phosphatidylethanolamine containing liposomes. Role of bilayer contact. Biochemistry. 23:1984;1532-1538.
61. Connor J., Yatvin M.B., Huang L. pH-sensitive liposomes: acid induced liposome fusion. Proc. Natl. Acad. Sci. USA. 81:1984;1715-1718.
62. Zhou F., Watkins S.C., Huang L. Characterization and kinetics of MHC class I-restricted presentation of a soluble antigen delivered by liposomes. Immunobiology. 190:1994;35-52.
63. Perry D.G., Martin W.J. II. Fluorescent liposomes as quantitative markers of phagocytosis by alveolar macrophages. J. Immunol. Methods. 181:1995;269-285.
64. Gregoriadis G., Buckland R.A. Enzyme-containing liposomes alleviate a model for storage disease. Nature. 244:1973;170-172.
65. Gaczynska M., Rock K.L., Goldberg A.L. Role of proteasomes in antigen presentation. Enzyme Protein. 47:1993;354-369.
66. Lowe J., Stock D., Jap B., Zwickl P., Baumeister W., Huber R. Crystal structure of the 20S proteasome from the Archaeon T. acidophilum at 3.4 Å resolution. Science. 268:1995;533-539.
67. Ortmann B., Copeman J., Lehner P.J., Sadasivan B., Herberg J.A., Grandea A.G., Riddell S.R., Tampe R., Spies T., Trowsdale J., Creswell P. A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science. 277:1997;1306-1309.
68. Roelse J., Gromme M., Momburg F., Hammerling G., Neefjes J.J. Trimming of TAP translocated peptides in the endoplasmic reticulum and in the cytosol during recycling. J. Exp. Med. 180:1994;1591-1597.
69. Bergeron J.J., Brenner M.B., Thomas D.Y., Williams D.B. Calnexin: a membrane-bound chaperone of the endoplasmic reticulum. Trends Biochem. Sci. 9:1994;124-128.
70. Jondal M., Schirmbeck R., Reimann J. MHC class I-restricted CTL responses to exogenous antigens. Immunity. 5:1996;295-302.
71. Neefjes J.J., Stollorz V., Peters P.J., Geuze H., Ploegh H.L. The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell. 61:1990;171-183.
72. Peters P.J., Neefjes J.J., Oorschot V., Ploegh H.L., Geuze H. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature. 349:1991;669-676.
73. Reise Sousa C., Germain R.N. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J. Exp. Med. 182:1995;841.
74. Pagano R.E., Sepanski M.A., Martin O.C. Molecular trapping of a fluorescent (NBD) ceramide analog at the Golgi apparatus of fixed cells: interaction with endogenous lipids provides a trans-Golgi marker for both light and electron microscopy. J. Cell Biol. 109:1989;2067-2079.
75. Kobayashi T., Pagano R.E. ATP-dependent fusion of liposomes with Golgi apparatus of perforated cells. Cell. 55:1988;797-805.
76. Kagiwada S., Murata M., Hishida S., Tagaya M., Yamashina S., Ohnishi S.I. In vitro fusion of rabbit liver Golgi membranes with liposomes. J. Biol. Chem. 268:1993;1430-1435.
77. Park S.H., Chiu Y.H., Jayawardena J., Roark J., Kavita U., Bendelac A. Innate and adaptive functions of the CD1 pathway of antigen presentation. Semin. Immunol. 10:1998;391-398.
78. Porcelli S.A., Segelke B.W., Sugita M., Wilson I.A., Brenner M.B. The CD1 family of lipid antigen-presenting molecules. Immunol. Today. 19:1998;362-368.
79. Blumberg R.S., Gerdes D., Chott A., Porcelli S.A., Balk S.P. Structure and function of the CD1 family of MHC-like cell surface proteins. Immunol. Rev. 147:1995;5-29.
80. Jackman R.M., Moody D.B., Porcelli S.A. Mechanisms of lipid antigen presentation by CD. Crit. Rev. Immunol. 19:1999;49-63.
81. Sugita M., Moody D.B., Jackman R.M., Grant E.P., Rosat J.P., Behar S.M., Peters P.J., Porcelli S.A., Brenner M.B. CD1 - a new paradigm for antigen presentation and T cell activation. Clin. Immunol. Immunopathol. 87:1998;8-14.
82. Grant E.P., Degano M., Rosat J.P., Stenger S., Modlin R.L., Wilson I.A., Porcelli S.A., Brenner M.B. Molecular recognition of lipid antigens by T cell receptors. J. Exp. Med. 189:1999;195-205.
83. Brossay L., Burdin N., Tangri S., Kronenberg M. Antigen-presenting function of mouse CD1: one molecule with two different kinds of antigenic ligands. Immunol. Rev. 163:1998;139-150.
84. Tangri S., Brossay L., Burdin N., Lee D.J., Corr M., Kronenberg M. Presentation of peptide antigens by mouse CD1 requires endosomal localization and protein antigen processing. Proc. Natl. Acad. Sci. USA. 95:1998;14314-14319.
85. Sugita M., Porcelli S.A., Brenner M.B. Assembly and retention of CD1b heavy chains in the endoplasmic reticulum. J. Immunol. 159:1997;2358-2365.
86. Sugita M., Jackman R.M., van Donselaar E., Behar S.M., Rogers R.A., Peters P.J., Brenner M.B., Porcelli S.A. Cytoplasmic tail-dependent localization of CD1b antigen-presenting molecules to MIICs. Science. 273:1996;349-352.
87. + T cells. Nature. 372:1994;691-694.